Study Summary
This trial will assess the feasibility of using a smartphone app to help manage anxiety and depression for cancer patients receiving radiation treatments.
Eligible Conditions
- Symptom Management
- Treatment Non-Adherence
Treatment Effectiveness
Phase-Based Effectiveness
N/A
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 8 weeks
8 weeks
Anxiety
Trial Safety
Phase-Based Safety
Awards & Highlights
No Placebo Group
All patients enrolled in this trial will receive the new treatment.
Trial Design
1 Treatment Group
Intervention group
1 of 1
Experimental Treatment
60 Total Participants · 1 Treatment Group
Primary Treatment: Intervention group · No Placebo Group · N/A
Intervention group
Behavioral
Experimental Group · 1 Intervention: Intervention group · Intervention Types: BehavioralTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intervention group
2016
N/A
~5470
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 8 weeks
Who is running the clinical trial?
University of OklahomaLead Sponsor
434 Previous Clinical Trials
99,423 Total Patients Enrolled
Eligibility Criteria
Age 18 - 99 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You have been diagnosed with breast, gynecological or head and neck cancer.
You live in the community, not in a hospital or institution.